300003.SZ · 乐普医疗
China A-shares · RS rating 25 · As of 2026-10-14
| Price | 11.44 CNY |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 25 / 68 / 42 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 14 / 19 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -7.8% |
| Distance from 52-week high | +44.2% |
| Market cap (USD) | $3.2B |